No, NAD+ is not a peptide. It's a dinucleotide, with no amino acids and no peptide bonds in it. It's sold beside peptides, discussed beside peptides and injected like peptides, and the distinction still isn't pedantry. It changes how you read the certificate that comes with the vial.
NAD+ is not a peptide. A peptide is a chain of amino acids joined by peptide bonds. NAD+ is a dinucleotide: two nucleotides joined by a phosphate bridge, with zero amino acids and zero peptide bonds. It appears in peptide catalogs because it shares the same research-use market, not because it shares the chemistry.
What makes something a peptide
A peptide is two or more amino acids joined by peptide bonds. That's the whole definition. The bond forms between one amino acid's carboxyl group and the next one's amino group, releasing water.
By that test, BPC-157 is a peptide: 15 amino acids in a chain. So is semaglutide. NAD+ fails at the first step, because it contains no amino acids at all.
Where the label still misleads you. Calling NAD+ a peptide is wrong, but the correction doesn't tell you anything about whether it works. Classification is chemistry, not evidence.
We'd keep the two questions apart. This page settles what the molecule is. It doesn't settle what it does.
What NAD+ actually is
NAD+ is nicotinamide adenine dinucleotide. That's two nucleotides, one carrying adenine and one carrying nicotinamide, joined through a pair of phosphate groups. Nucleotides are the units that build DNA and RNA, not proteins.
Its job is redox chemistry. It accepts and donates electrons, cycling between NAD+ and NADH, which is what makes it central to energy metabolism.
NAD+
The NAD+ discussed here, supplied as a research compound with a certificate of analysis matched to the lot.
Why it sits in peptide catalogs
Market, not chemistry. NAD+ sells as a research compound through the same channels. It reconstitutes from a lyophilized powder the same way, and the same people buy it for the same broad reason.
The practical overlap is real, and the classification is still wrong. It matters most when you're reading a certificate of analysis, because purity on a dinucleotide isn't assessed the way purity on a peptide chain is.
- Don't expect an amino-acid analysis. There's nothing for it to measure, so its absence on an NAD+ certificate is correct rather than a gap.
- Expect HPLC purity and mass-spec identity. Those apply to any small molecule, and they're what we'd hold an NAD+ lot to.
- Watch the degradation question instead. NAD+ is a redox-active molecule, so what you want confirmed is that the vial holds NAD+ rather than its breakdown products.
NAD+
Research-use-only material, sold by the vial with batch documentation. Check the certificate of analysis against the batch you receive.
What to know now
- NAD+ is a dinucleotide, not a peptide. No amino acids, no peptide bonds.
- A peptide is two or more amino acids joined by peptide bonds — NAD+ has none.
- It is built from nucleotides, the units of DNA and RNA, not the units of protein.
- It appears in peptide catalogs because it shares the research-use market, not the chemistry.
- The label matters for handling: purity on a dinucleotide is not assessed the way it is on a peptide chain.
What we're watching
Nothing about the classification is contested. We're watching whether suppliers start separating the categories on their own listings, which would make certificates easier for you to read.
Frequently asked questions
Is NAD+ an amino acid?
No. NAD+ contains no amino acids. It is built from two nucleotides joined by phosphate groups.
Is NMN a peptide?
No. NMN is a nucleotide and a direct precursor to NAD+. Like NAD+, it contains no amino acids.
References
- Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141. https://doi.org/10.1038/s41580-020-00313-x
- Yoshino, J., Baur, J. A., & Imai, S. I. (2018). NAD+ intermediates: The biology and therapeutic potential of NMN and NR. Cell Metabolism, 27(3), 513–528. https://doi.org/10.1016/j.cmet.2017.11.002
- Martens, C. R., Denman, B. A., Mazzo, M. R., et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 9(1), 1286. https://doi.org/10.1038/s41467-018-03421-7